首页> 外文OA文献 >Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: Comparison of SPECT-CT, SPECT, and planar imaging
【2h】

Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: Comparison of SPECT-CT, SPECT, and planar imaging

机译:原发性甲状旁腺功能亢进并发结节性甲状腺肿的术前99mTc-司他他比闪烁显像:SPECT-CT,SPECT和平面成像的比较

摘要

Background: Investigations using a hybrid single photon emission computed tomography/computed tomography (SPECT-CT) scanning technique have been carried out in limited studies and have shown mixed results. However, the assessment of this technique for the detection of parathyroid adenoma in patients with a nodular goiter was performed in only one study with a small sample size. The aim of this prospective study was to assess the role of Tc-sestamibi parathyroid SPECT-CT scans for localization of parathyroid adenomas with a concomitant nodular goiter using Tc-methoxyisobutyl isonitrile (MIBI) scintigraphy and to compare it with SPECT and planar imaging. Methods: This study was conducted on 48 patients with primary hyperparathyroidism and nodular goiter, who were candidates for parathyroid surgery and had been referred for parathyroid scintigraphy. The patients underwent an early set of planar Tc-MIBI scanning procedures first, followed by SPECT and CT scannings, and finally a delayed set of planar Tc-MIBI scannings. Sensitivity, specificity, negative and positive predictive values, and accuracy were determined on a per-parathyroid-gland basis for each scanning method, as defined by histology and follow-up. Results: The surgery was successful in 48 out of 50 patients with primary hyperparathyroidism concomitant with thyroid nodularity, and data were completed for 80 sites in 48 patients. The accuracy of SPECT-CT in correctly identifying a parathyroid adenoma was 85.00, versus 75.00% for SPECT (P=0.01, significant). The sensitivity and specificity for SPECT-CT were 77.55 and 96.77%, respectively, versus 67.34 and 87.09%, respectively, for SPECT (P=0.12 and 0.12, not significant). There were nine sites that showed better localization on SPECT-CT scans relative to SPECT images, of which five sites were located in the ectopic regions. Conclusion: The results of our study indicate that SPECT-CT is more accurate than sestamibi planar imaging and SPECT for the preoperative identification of parathyroid lesions in patients with primary hyperparathyroidism concomitant with thyroid nodularity. Also, we would recommend the use of SPECT-CT for a workup of all patients with ectopic glands who are scheduled for minimally invasive parathyroid surgery. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
机译:背景:在有限的研究中,使用混合单光子发射计算机断层扫描/计算机断层扫描(SPECT-CT)扫描技术进行了研究,并显示出不同的结果。但是,仅在一项样本量较小的研究中,对该技术对结节性甲状腺肿患者甲状旁腺腺瘤的检测进行了评估。这项前瞻性研究的目的是评估Tc-Sestamibi甲状旁腺SPECT-CT扫描在伴有结节性甲状腺肿中使用Tc-甲氧基异丁基异腈(MIBI)闪烁显像技术对甲状旁腺腺瘤定位的作用,并将其与SPECT和平面成像进行比较。方法:本研究针对48例原发性甲状旁腺功能亢进症和结节性甲状腺肿患者进行了甲状旁腺闪烁显像术,这些患者可进行甲状旁腺手术。患者首先接受早期的平面Tc-MIBI扫描程序,然后进行SPECT和CT扫描,最后进行一组延迟的平面Tc-MIBI扫描。敏感性,特异性,阴性和阳性预测值以及准确性是根据组织学和随访定义的每种扫描方法在每个甲状旁腺中确定的。结果:50例原发性甲状旁腺功能亢进症伴有甲状腺结节的患者中有48例手术成功,并完成了48例患者的80个部位的数据。 SPECT-CT正确识别甲状旁腺腺瘤的准确性为85.00,而SPECT为75.00%(P = 0.01,显着)。 SPECT-CT的敏感性和特异性分别为77.55和96.77%,而SPECT的敏感性和特异性分别为67.34和87.09%(P = 0.12和0.12,不显着)。相对于SPECT图像,有9个位点在SPECT-CT扫描中显示出更好的定位,其中5个位点位于异位区域。结论:我们的研究结果表明,在原发性甲状旁腺功能亢进并发甲状腺结节的患者中,SPECT-CT的术前识别甲状旁腺病变的准确性比sestamibi平面成像和SPECT准确。另外,我们建议使用SPECT-CT对所有计划进行微创甲状旁腺手术的异位腺患者进行检查。 ©2012 Wolters Kluwer Health |版权所有|利平科特·威廉姆斯和威尔金斯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号